News
Is It Too Late to Buy CRISPR Therapeutics Stock?
CRISPR Therapeutics (NASDAQ: CRSP) is gaining in prominence. The gene-editing specialist has made tremendous clinical and regulatory progress since its 2016 initial public offering, leading to
Why Jabil Stock Dropped 12% Today
Jabil (NYSE: JBL) stock tumbled 12.5% through 10:20 a.m. ET Friday morning after the stock reported mixed earnings and gave weak guidance in its fiscal Q2 2024 financial report.
Heading into the
Duolingo Stock Tripled in 2023, and Here's Why It Could Go Higher
Duolingo (NASDAQ: DUOL) is the world's most popular digital language education platform, and its stock was a top performer in 2023 with a 219% gain. The company routinely beat its own quarterly
The Biggest Loser in the "Magnificent Seven" Could Soar 1,140%, According to Cathie Wood's Ark Invest
The "Magnificent Seven" is a group of the world's largest technology stocks. They delivered an average return of 112% last year, led by Nvidia, which gained a whopping 239%.
Nvidia continues to lead
1 Beaten-Down Stock That's Still Not Worth Buying
Investing basics tell us to "buy low" and invest in a stock when there looks to be significant upside potential. That can often be after a company gets put through the wringer and the stock declines
Got $20? Buy This Korean E-commerce Stock Before It's Too Late
Last week was a big one for Coupang (NYSE: CPNG). The Korea-based e-commerce platform reported its full-year earnings and saw its stock pop more than 10% after putting up strong growth and
1 Beaten-Down Stock With 55% Upside, According to Wall Street
Although equities have performed pretty well in the past three years, many somewhat speculative and unprofitable stocks have struggled as investors have turned their attention away from such
If You Invested $5,000 in Canopy Growth in 2019, This Is How Much You Would Have Today
Time flies on the stock market. It now seems so long ago that people rushed to invest in cannabis stocks following positive regulatory developments, especially in Canada. Unfortunately, the industry
Could These 3 Companies Headline a "Magnificent Seven" of Biotech Stocks?
The "Magnificent Seven," a group of market-leading tech companies, is so named for several reasons. Here are three: First, they've all delivered outsized returns over the past decade or so. Second
1 No-Brainer Vanguard Fund to Buy Right Now
The U.S. stock market currently stands on shaky ground. The stark difference between high borrowing costs and the rise of powerful growth trends like artificial intelligence (AI) and weight-loss
Is Vanguard Total Stock Market ETF a Buy?
Some investors just want everything -- and they can have it if they buy Vanguard Total Stock Market ETF (NYSEMKT: VTI). That's only sort of a joke. The real story here is that this highly
How This Top Restaurant Stock Pulled Off a 40% Return in a Year
After an incredibly difficult period during the pandemic, plus tragically losing its founder and CEO, the late Wayne Kent Taylor, Texas Roadhouse (NASDAQ: TXRH) stock is back. Total return (stock
Vanguard Total Stock Market ETF: Buy, Sell, or Hold?
The broader stock market can be a loaded topic because the market is diverse, and different types of stocks go up and down at various times. Generally speaking, the S&P 500 is the most common
If You Invested $10,000 in CRISPR Therapeutics in 2019, This Is How Much You Would Have Today
Companies in the biotech industry are often capable of delivering explosive returns, especially those with a knack for innovation and breaking new ground. That describes CRISPR Therapeutics (NASDAQ:
Is Vanguard Total Stock Market ETF a Millionaire Maker?
There's no right way to invest, with various approaches (like value, growth, and growth plus income) all offering the potential for investors to build a million-dollar nest egg. The bigger question
Why American Well Corporation Stock Soared Today
Shares of American Well (NYSE: AMWL), also known as Amwell, are up 20.7% as of 2 p.m. ET Thursday after the telemedicine company announced better-than-expected fourth-quarter 2023 results.
American
Prediction: Solana Will Reach $260 In 2025
In 2023, Solana (CRYPTO: SOL) was one of the best-performing cryptocurrencies, up more than 1,000% for the year at one point. While that performance might be impossible to top in 2024, there's
Why Spotify Stock Jumped as Much as 11.4% Today
Spotify (NYSE: SPOT) reported better than expected fourth-quarter financial results before the market opened on Tuesday, and shares promptly jumped by 11.4%. But as the day wore on, the enthusiasm
Did the "Magnificent Seven" Just Become the "Super Six?"
The S&P 500 index delivered a gain of 24.3% last year, but it was led higher by a group of stocks dubbed the "Magnificent Seven." This cohort includes:
The companies have a combined market value of
Is Vanguard Total Stock Market ETF a Buy?
Investors looking for an easy way to add U.S. equity exposure to their portfolios will probably find Vanguard Total Stock Market ETF (NYSEMKT: VTI) of interest. That said, while it does some things
If You Invested $5,000 in Aurora Cannabis in 2019, This Is How Much You Would Have Today
When Canada legalized adult uses of cannabis in late 2018, investors rushed to buy shares of what looked like the most promising companies in the field. Aurora Cannabis (NASDAQ: ACB) was one of the
Yielding Close to 10%, Is This Tobacco Stock Safe for Dividend Investors in 2024?
For decades, tobacco stocks were the cream of the crop when it came to investment performance. Despite years and years of volume declines in the United States and other markets, sellers of
Here's How Much You Could Earn in Dividends From "Magnificent Seven" Stocks Apple, Microsoft, and Nvidia
The "Magnificent Seven" refers to a group of the world's largest technology stocks, which have a combined market capitalization of $12.7 trillion. Given that sheer size, they represent 28.7% of the
If You Invested $5,000 in Novo Nordisk in 2019, This Is How Much You Would Have Today
Pharma giant Novo Nordisk (NYSE: NVO) made a lot of noise last year. The company's shares crushed the otherwise high-flying market thanks to its work in the anti-obesity drug space. However, Novo
If You Invested $1,000 in Bluebird Bio in 2019, This Is How Much You Would Have Today
Gene-editing specialist Bluebird Bio (NASDAQ: BLUE) has been making plenty of noise since 2019, which is when it first earned marketing authorization for one of its breakthrough therapies